Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial
Odile Launay, Christine Durier, Corinne Desaint et al. · 2007
Read Cellular Immune Responses Induced with Dose-Sparing Intradermal Administration of HIV Vaccine to HIV-Uninfected Volunteers in the ANRS VAC16 Trial by Odile Launay, Christine Durier, Corinne Desaint et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000725.txt.
Description
Odile Launay, Christine Durier, Corinne Desaint and colleagues compared two routes for delivering an HIV vaccine in the ANRS VAC16 trial. Their 2007 PLOS ONE objective was safety and cellular immune response. Healthy, HIV-uninfected volunteers received a candidate vaccine called LIPO-4, built from HIV lipopeptides. One group got it intradermally, into the skin; the other intramuscularly, into muscle.
The trial was randomized and open-label, run in France at six sites with 24 weeks of follow-up. Intradermal delivery is dose-sparing, stretching limited vaccine further. If skin delivery with less vaccine matches muscle delivery, vaccination campaigns gain reach. Cellular responses, T cell reactions, were the measure that mattered here.
Catalog record
| CREATOR | Odile Launay, Christine Durier, Corinne Desaint et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000725